Verano Holdings Corp. (VRNOF)

Sage Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	84.22	87.8	174.76	84.85	99.12	16.4
Cash & Short-Term Investments	84.22	87.8	174.76	84.85	99.12	16.4
Cash Growth	-56.54%	-49.76%	105.96%	-14.39%	504.30%	155.57%
Accounts Receivable	40.02	40.26	38.98	16.58	17.41	7.27
Other Receivables	-	-	-	-	-	0.11
Receivables	40.02	40.26	38.98	16.58	17.7	11.32
Inventory	192.26	184.46	155.77	164.53	140.7	37.35
Prepaid Expenses	14.07	12.84	22.73	48.88	19.53	6.17
Other Current Assets	30.58	32.15	1.96	3.43	-	-
Total Current Assets	361.14	357.51	394.2	318.28	277.04	71.25
Property, Plant & Equipment	629.68	637.88	594.76	608.18	513.58	155.97
Long-Term Investments	-	-	2.29	8.78	7.49	11.55
Goodwill	247.6	246.23	231.29	269.09	368.13	16.03
Other Intangible Assets	717.26	734.01	1,086	1,181	1,380	72.42
Other Long-Term Assets	13.3	13.33	10.06	10.96	2.5	2.44
Total Assets	1,969	1,989	2,319	2,396	2,549	329.65
Accounts Payable	45.4	39.93	31.28	40.5	45.17	18.29
Accrued Expenses	51.58	61.49	60.99	38.18	39.53	11.83
Current Portion of Long-Term Debt	16.8	18.15	52.01	24.46	13.77	7.81
Current Portion of Leases	11.41	11.25	9.75	8.89	6.56	1.8
Current Income Taxes Payable	34.96	58.76	248.47	252.77	154.51	41.16
Current Unearned Revenue	6.88	7.45	5.78	3.58	2.62	2.06
Other Current Liabilities	0.61	0.94	3.92	18.26	208.35	33.34
Total Current Liabilities	167.64	197.97	412.19	386.65	470.52	116.29
Long-Term Debt	403.83	395.7	393.64	388.54	276.15	32.48
Long-Term Leases	96.68	97.88	87.4	76.85	56.81	10.62
Long-Term Unearned Revenue	-	-	-	-	1.18	2.04
Long-Term Deferred Tax Liabilities	72.98	74.1	182.22	196.47	262.18	14.82
Other Long-Term Liabilities	286.25	272.49	3.23	5.99	-	-
Total Liabilities	1,027	1,038	1,079	1,055	1,067	176.25
Common Stock	1,738	1,736	1,682	1,666	1,536	137.91
Retained Earnings	-795.12	-783.61	-441.75	-324.4	-55.24	9.25
Comprehensive Income & Other	0.01	0.01	-0.01	-0.01	-	-
Total Common Equity	943.38	952.17	1,240	1,342	1,481	147.16
Minority Interest	-1.78	-1.36	-	-	1.28	6.24
Shareholders' Equity	941.6	950.82	1,240	1,342	1,482	153.4
Total Liabilities & Equity	1,969	1,989	2,319	2,396	2,549	329.65
Total Debt	528.71	522.98	542.79	498.75	353.3	52.72
Net Cash (Debt)	-444.49	-435.19	-368.03	-413.9	-254.18	-36.32
Net Cash Per Share	-1.26	-1.24	-1.07	-1.25	-0.88	-0.13
Filing Date Shares Outstanding	359.72	358.95	344.07	341.77	327.87	293.2
Total Common Shares Outstanding	359.72	358.75	344.07	339.98	324.31	16.03
Working Capital	193.5	159.54	-17.99	-68.37	-193.47	-45.04
Book Value Per Share	2.62	2.65	3.60	3.95	4.57	9.18
Tangible Book Value	-21.48	-28.06	-77.36	-108.3	-267.51	58.71
Tangible Book Value Per Share	-0.06	-0.08	-0.22	-0.32	-0.82	3.66
Land	29.03	29.03	30.93	31.88	29.4	12.14
Buildings	171.28	173.43	194.27	197.82	126.02	15.22
Machinery	155.3	152.33	140.5	131.17	96.34	36.88
Construction In Progress	97.08	96.98	39.84	41.8	64.11	8.51
Leasehold Improvements	272.69	268.84	230.88	211.79	182.51	89.39

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.